Skip to content

Solutions

Solutions Powered by Class-leading Technology

For discovery of new biology and biomarkers, development of revolutionary applications, diagnosis of early disease, and delivery of preventive and precision healthcare. 

Our end-to-end solutions

Discover

Research & development

  • Tools for RNA-centric discovery.
  • Solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases.

Develop

Manufacturing & commercialization

  • ISO 13485 certified, Industry 4.0 diagnostics manufacturing.
  • Bringing high quality products to market at affordable cost.

Diagnose

Clinical
service

  • Multi-omics testing for novel insights, improved early screening, and precision medicine.
  • Delivering accurate results.

Deliver

Healthcare solutions

  • Promote dynamic prevention to improve healthcare and health economics.
  • Partnering Insurtech and Telehealth

Our technology

Patented RT-qPCR Technology

Our patented reverse transcription-quantitative polymerase chain reaction (RT-qPCR) technology enables sensitive, specific, and robust detection of microRNA and other RNAs in biofluid and tissue samples. 

Independently validated to be more sensitive than other RT-qPCR technologies for microRNA quantification.

Explainer video

MiRXES technology platform

Play Video

Our products and pipeline

Early cancer
screening

GASTROClear Test

The world's first RNA blood test for early detection of gastric cancer

In the pipeline:

5 tests for early cancer detection:

0%
Gastric Cancer
0%
Lung Cancer
0%
Breast Cancer
0%
Colorectal Cancer
0%
Ovarian Cancer
0%
Liver Cancer

Infectious, cardiovascular, and metabolic diseases

Fortitude Kit

A SARS-CoV-2 RT-PCR test for accurate testing of COVID-19

In the pipeline:

1 test for
infectious disease.

3 tests for cardiovascular and metabolic diseases.

0%
COVID-19
0%
Heart Failure
0%
Pulmonary Hypertension
0%
Sepsis
0%
Insulin Resistance

Discovery and
development

ID3EAL Suite

Versatile market-leading microRNA research solutions for scientists

In the pipeline:

2 new ID3EAL microRNA knowledge panels.

0%
Cancer microRNA Panel
0%
Biofluid microRNA Panel
0%
Stem Cell microRNA Panel
0%
Disease-relevant microRNA Panel
0%
Viral microRNA Panel

Find out more

Accurate, actionable, and affordable molecular diagnostic solutions

Versatile market-leading research solutions

Research, co-development, and IP licensing collaborations